Variation in the monoamine-oxidase-A (MAO-A) gene has been associated with volumetric changes in corticolimbic regions with differences in their response to relevant emotional tasks. Here we show no changes in baseline regional brain metabolism as a function of genotype indicating that, unchallenged, corticolimbic activity is not modulated by the MAO-A genotype. Published by Elsevier Ireland Ltd.
Introduction
Monoamine oxidase A (MAO-A) degrades neurotransmitters, including serotonin, dopamine and norepinephrine implicated in regulating mood and behavior (Shih and Thompson, 1999) . A functional polymorphism in the MAO-A gene promoter is described as 4-tandemrepeats (high MAO-A activity) in 60% and 3-repeats (low MAO-A activity) in 40% in healthy men (Sabol et al., 1998) . Studies in humans (Foley et al., 2004) and primates (Newman et al., 2005 ) support a link between the low MAO-A genotype and susceptibility to antisocial behavior in the face of childhood maltreatment. Functional magnetic resonance imaging (fMRI) studies found that healthy subjects with the low MAO-A genotype have mostly reduced volume (Meyer-Lindenberg et al., 2006) and different patterns of cortical activity in the performance of cognitive and emotional tasks compared with the high MAO-A genotype (Fan et al., 2003; Passamonti et al., 2006; Meyer-Lindenberg et al., 2006) .
It is not known, however, whether brain function assessed in a resting condition, as opposed to a cognitive or emotional task, would differ as a function of the MAO-A genotype. As compared with fMRI, glucose utilization measured by PET is a quantifiable and absolute measure of brain activity. Using the aggregation of brain activity over time without a specific challenge, yet with subjects in an alert state, may provide an informative gestalt of baseline 
